NHS England to fund Duodopa

News

Author: Parkinson's Life editorsPublished: 28 August 2015

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

News image

The NHS in England has announced they will fund Duodopa – a life-changing drug for people with advanced Parkinson’s – after campaigners managed to garner the support of nearly a hundred MPs who signed a petition.

This means that should a specialist Parkinson’s clinician prescribe Duodopa, a patient will be able to receive it without delay. Duodopa can help to control the symptoms of advanced Parkinson’s when all other treatments have stopped working.

The petition signed by 98 MPs put pressure on NHS England to act urgently to address the situation.

Laura Cockram, policy and campaigns manager at Parkinson’s UK said: “I am elated that the NHS has finally arrived at this decision. We know this treatment has had transformative effects on many that have been treated with it and how vital it is that those who need Duodopa receive it without delay. This is an important day for Parkinson’s care.”

 

Go Back

Share this story

Comments


Related articles


CVT-301 Inhaler lead

Advances

Fast-acting inhalable levodopa produces positive results in clinical trial

Is inhalable levodopa for treating Parkinson’s one step closer?

READ MORE
MDS Summer School for Nurses

PD in Practice

Aspiring Parkinson’s nurses urged to apply for “hands-on” summer school in Portugal

A unique opportunity to bring Parkinson’s nurses together

READ MORE

Women and Parkinson's

Women and Parkinson’s: menstruation, medication and motherhood

Our podcast shines a light on how women experience the condition

READ MORE